Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow

G Rothe1, G Schmitz

  • 1Institute for Clinical Chemistry, University of Regensburg, Germany.

Leukemia
|May 1, 1996
PubMed

Insights

Flow cytometry is crucial for diagnosing acute leukemias and lymphomas by analyzing malignant cells. Standardizing flow cytometry protocols ensures reliable results across laboratories for better quality assurance and future technologies.

Area of Science:

  • Hematology
  • Immunology
  • Clinical Pathology

Background:

  • Flow cytometry is the gold standard for lineage assignment and maturational analysis in hematological malignancies.
  • Multiparametric immunophenotyping aids in detecting aberrant antigen coexpression, heterogeneity, and clonality in leukemias and lymphomas.

Framework:

  • Standardization of flow cytometry protocols is essential for interlaboratory reproducibility in clinical settings.
  • A consensus protocol initiative aims to establish standardized methods for phenotyping hematological neoplasias.

Implementation:

  • Recommendations cover general assay procedures, quality control, and specific two-color reagent panel selection.
  • Guidance is provided for data interpretation to enable cross-evaluation of laboratory protocols.

Implications:

  • Standardized protocols will form the basis for quality assurance in flow cytometry analysis.
  • This initiative supports the integration of emerging technologies like quantitative antigen density analysis and automated knowledge-based software.